X

Xenon Pharmaceuticals
D

XENE

38.230
USD
0.27
(0.72%)
مغلق
حجم التداول
34,173
الربح لكل سهم
-5
العائد الربحي
-
P/E
-11
حجم السوق
2,947,754,696
أصول ذات صلة
A
AKRO
-0.720
(-1.44%)
49.390 USD
AMGN
AMGN
6.28
(2.16%)
296.49 USD
A
ARCT
0.275
(1.43%)
19.520 USD
BIIB
BIIB
3.680
(2.73%)
138.670 USD
F
FULC
0.21500
(3.26%)
6.81000 USD
GOOGL
GOOGL
1.040
(0.51%)
203.910 USD
المزيد
الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.